DABACO Group

DABACO Group

HHOSE:DBC
16,050.00
VND
-100.00
(-0.62%)
8.00TMarket Cap
Dec 02Next Earn
DABACO Group
HOSE:DBC
(Ho Chi Minh Stock Exchange)

Recent

price

16,050.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
VND
23,643.96
22,630.48
23,852.53
18,476.56
19,755.07
18,381.45
18,050.86
16,895.38
19,258.17
19,835.37
27,659.67
29,843.54
31,899.2
31,225.44
31,489.39
34,561.3
- -
Revenue per Share
1,655.61
1,273.22
1,247.69
750.76
783.73
802.48
1,301.95
577.38
1,039.43
842.16
3,864.83
2,289.6
14.34
70.28
1,784.21
3,495.57
- -
Basic EPS, GAAP
-5,917.89
-2,716.57
357.71
-714.48
784.43
-309.45
-1,948.02
-3,335.1
-2,042.17
-1,007.13
4,417.28
800.12
-2,420.91
-3,772.94
592.8
949.71
- -
Free Cash Flow per Basic Share
187.08
210.58
728.25
55.26
334.55
398.28
105.39
3.23
238.97
- -
559.44
627.63
- -
- -
- -
1,164.54
- -
Dividend per Share
20,664.6
19,442.21
19,580.27
18,909.27
20,090.41
21,365.76
25,676.4
27,471
30,148.4
8,731.15
11,611.17
12,933.2
12,809.89
12,878.91
15,694.28
18,717.09
19,766.1
Book Value per Share
20,332.44
19,267.61
19,440.28
18,831.44
20,025.55
21,313.87
25,637.48
27,445.05
30,135.43
8,731.15
11,611.17
12,933.2
12,809.89
12,878.91
15,694.28
18,717.09
19,766.1
Tangible Book Value per Share
106
173
200
255
263
315
347
347
347
362
362
362
362
356
431
431
417
Basic Weighted Avg Shares
2,517,777
3,917,986
4,774,351
4,704,280
5,186,838
5,791,393
6,255,923
5,855,465
6,674,305
7,186,757
10,021,584
10,812,795
11,557,595
11,110,001
13,573,523
14,897,670
- -
Sales/Revenue/Turnover
9.76
7.43
7.82
6.59
6.82
6.7
7.04
5.61
8.08
8.42
18.34
10.44
2.16
3.08
8.01
12.11
- -
Operating Margin (%)
38,704
65,383
84,822
105,564
131,388
170,940
194,703
140,746
259,495
312,350
465,912
491,248
497,034
547,283
639,208
656,090
- -
Depreciation Expense
176,301
220,430
249,739
191,150
205,773
252,836
451,219
200,105
360,235
305,130
1,400,296
829,558
5,195
25,007
769,084
1,506,768
- -
Net Income, GAAP
12.89
7.29
18.28
20.54
17.41
10.85
13.68
28.23
8.42
11.57
9.89
15.32
93.42
74.42
9.97
7.19
- -
Effective Tax Rate (%)
7
5.63
5.23
4.06
3.97
4.37
7.21
3.42
5.4
4.25
13.97
7.67
0.04
0.23
5.67
10.11
- -
Profit Margin (%)
362,881
991,233
716,526
856,357
761,315
707,973
598,629
-134,462
-304,192
-441,814
398,505
465,769
-147,899
-40,365
1,417,446
2,803,444
2,612,575
Working Capital
432,167
509,978
145,104
125,536
167,892
248,956
555,158
1,013,302
1,287,160
1,415,230
1,243,519
687,235
886,249
1,026,415
764,297
1,106,441
1,631,306
LT Debt
775,327
1,231,145
1,376,322
1,722,659
1,830,262
1,946,448
2,339,142
2,502,617
2,746,528
3,025,957
4,206,960
4,685,923
4,641,228
4,666,235
6,766,080
8,069,062
8,521,241
Total Equity
10.76
8.69
8.09
5.38
6.22
7.19
7.61
3.74
5.61
4.14
18.08
10.01
0.03
0.2
6.51
11.2
- -
Return on Invested Capital (%)
15.9
14.52
12.63
9.16
9.35
9.73
13.09
5.47
8.5
7.69
21.97
12.63
0.2
0.93
8.75
13.25
- -
Return on Capital (%)
25.75
22.1
19.16
12.34
11.58
13.39
21.06
8.27
13.73
10.57
38.72
18.66
0.11
0.54
13.46
20.32
- -
Return on Common Equity (%)

Capital Structure

VND

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
4,770,218
4,071,047
5,609,854
LT Borrowings
940,171
1,168,860
1,264,368
LT Finance Leases
166,270
153,740
366,938
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
431
431
431
Market Capitalization
10,410,643
8,928,907
7,995,990

Working Capital

VND

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
9,449,734
8,261,724
10,046,959
Cash, Cash Equivalents & STI
2,271,409
2,263,286
2,760,602
Accounts Receivable, Net
269,379
267,400
371,047
Inventories
6,358,115
5,127,820
6,229,953
Total Current Liabilities
6,646,289
5,782,378
7,434,384
Payables & Accruals
- -
- -
- -
ST Debt
4,770,218
4,071,047
5,609,854
Deferred Revenue
- -
- -
- -

Growth Rates

VND

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
16.14%
15.05%
19.26%
Free Cash Flow
-45.24%
-98.05%
60.21%
Net Income, GAAP
375.91%
662.53%
95.92%
Sales/Revenue/Turnover
10.56%
8.57%
9.76%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

VND

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
3,252,592
3,184,669
3,525,028
3,611,234
13,573,523
2025
3,609,350
3,820,096
- -
3,729,046
14,897,670
2026
4,124,178
4,252,838
- -
- -
- -

Quarterly Earnings Per Share

VND

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
232.92
466.61
724.2
637.5
1,784.21
2025
1,356.25
1,515
- -
344.64
3,495.57
2026
867.86
671
- -
- -
- -

Quarterly Dividends Per Share

VND

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
1,164.54
2026
- -
- -
- -
- -
- -
Business
Dabaco Group Joint Stock Company is a Vietnam-based diversified agribusiness conglomerate primarily engaged in the integrated agriculture, livestock, and food processing value chain operating under the Feed-Farm-Food (3F) model. The company operates across multiple core business segments: Animal Feed, Livestock Breeding and Farming, Food Processing, Vegetable Oil Extraction, Animal Health and Biotechnology, and Real Estate and Industrial Infrastructure. Its comprehensive product and service portfolio comprises animal feed manufacturing for swine, poultry, cattle, and aquaculture under brand names such as Dabaco, Topfeeds, Kinh Bac, Khangti Vina, and Nasaco; livestock breeding and commercial farming operations, including grandparent and parent breeding pigs, commercial swine, colored broilers, and laying hens; fresh and processed meat products, including chilled pork, poultry, sausages, ham, canned meats, and pasteurized table eggs under the Dabaco and Devi brands; edible vegetable oil production and soybean meal processing via its dedicated crushing facilities under the Coba and Umi brands; veterinary pharmaceuticals, biological products, and specialized livestock vaccines; packaging manufacturing, including polypropylene (PP) and polyethylene (PE) woven bags; and real estate development, encompassing industrial park infrastructure, urban residential projects, civil construction, and retail supermarket chains under the Dabaco Mart banner. Founded in 1996 and headquartered in Bac Ninh Province, Vietnam, the company primarily operates across northern and central Vietnam while progressively expanding its trade and distribution channels internationally. In recent major developments, Dabaco Group has advanced the commercialization and international distribution readiness of its proprietary African Swine Fever (ASF) vaccine, Dacovac-ASF2, following the commissioning of its high-tech veterinary vaccine manufacturing facility and completion of regulatory field evaluations. The company has formed strategic partnerships with international livestock and biotechnology enterprises to advance animal genetics transfer, biosecurity standards, and cross-border vaccine distribution. Furthermore, Dabaco has executed capital increase initiatives and allocated funding toward the expansion of mega-scale high-tech pig farming complexes in provinces such as Thanh Hoa, Binh Phuoc, and Hoa Binh, alongside the phase-two capacity expansion of its soybean oil extraction and refining plant.